Uniqure

QURE NASDAQ
77.84
-3.31
-4.07%
交易中 15:30 06/18 EDT
开盘
79.98
昨收
81.14
最高
79.98
最低
73.55
成交量
142.78万
成交均量(3M)
61.72万
52周最高
81.37
52周最低
21.98
换手率
3.78%
市值
29.42亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Uniqure QURE股票价格,Uniqure股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Uniqure NV is a gene therapy company based in the Netherlands. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company advances a focused pipeline of gene therapies that are developed both internally and through partnerships. The Company’s product candidates within the Core Program include AMT-061 for Hemophilia B, AMT-130 for Huntington's disease and S100A1 for congestive heart failure. The Company, through its collaboration with Bristol Myers-Squibb (BMS), is focused on building a portfolio of gene therapies led by the S100A1 program for congestive heart failure.
展开 >

最近浏览

名称
价格
涨跌幅